Cherry Hill, NJ, United States of America

Kar Muthumani

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kar Muthumani

Introduction

Kar Muthumani, a distinguished inventor located in Cherry Hill, NJ, has made significant strides in the field of biotechnology with a total of nine patents to her name. Her innovative work primarily centers on developing vaccines and immunotherapies that combat emerging viral threats.

Latest Patents

Among her notable recent inventions, Muthumani has created a DNA vaccine targeting the Crimean-Congo hemorrhagic fever virus (CCHFV). This groundbreaking patent encompasses nucleic acid molecules and compositions that encode consensus antigens for CCHFV, as well as immunomodulatory methods aimed at inducing immune responses against this deadly virus. Furthermore, her research delves into the Mayaro virus, where she has disclosed a composition containing nucleic acid sequences that effectively elicit an immune response in mammals. This includes methods for generating synthetic antibodies that can prevent or treat Mayaro virus infections.

Career Highlights

Throughout her career, Muthumani has been associated with reputable institutions such as the Wistar Institute of Anatomy & Biology and Inovio Pharmaceuticals, Inc. Her contributions to the pharmaceutical and research communities have provided vital advancements in vaccine development, impacting both public health and scientific understanding of viral diseases.

Collaborations

Kar has collaborated with esteemed colleagues in the field, including David B. Weiner and Trevor R. F. Smith. These partnerships not only enhance her research efforts but also facilitate the exchange of ideas that drive innovation in vaccine technology.

Conclusion

Kar Muthumani's contributions to biotech innovation exemplify the critical role inventors play in addressing global health challenges. With her extensive patent portfolio and collaborative spirit, she continues to push the boundaries of what is possible in the fight against infectious diseases. Her ongoing work is a testament to the importance of research and innovation in safeguarding public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…